Forma Therapeutics Adds Kelly, Shegog, and Wadlinger to C-Suite

Forma Therapeutics has promoted Patrick Kelly to senior vice president and chief medical officer. Kelly previously led translational clinical activities for Watertown, MA-based Forma. In other moves, Mary Wadlinger was promoted from senior vice president of human resources to senior vice president of corporate affairs and chief human resources officer. Forma also named Todd Shegog its chief financial officer, the same position he previously held at Synlogic (NASDAQ: [[ticker:SYBX]]). Forma’s most advanced compound, olutasidenib, is in a pivotal Phase 2 study testing it in acute myeloid leukemia.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan